Jamp To Offer Canadian Sitagliptin, Sandoz Bags Fixed-Dose Combo
Sandoz Launches Immediately, Jamp Says Product Available Soon
Executive Summary
An important mono- and adjunct therapy for diabetes patients now has generic competition in Canada, where an estimated 10% of the population are said to have been diagnosed with type 1 or type 2 diabetes.